Sage Therapeutics (NASDAQ:SAGE) Receives New Coverage from Analysts at Deutsche Bank Aktiengesellschaft
Equities researchers at Deutsche Bank Aktiengesellschaft began coverage on shares of Sage Therapeutics (NASDAQ:SAGE – Get Free Report) in a research report issued to clients and investors on Tuesday, MarketBeat reports. The firm set a “hold” rating and a $21.00 price target on the biopharmaceutical company’s stock. Deutsche Bank Aktiengesellschaft’s target price would suggest a […]
More Stories
Netflix’s 10 Best Documentaries in 2026 That You Must Watch
There are tons of documentaries released in the blink of an eye in 2026. All these documentaries are based on...
Jason Biggs and Jenny Mollen Split After 18 Years of Marriage
Shocking news! Jason and his wife, Mollen, have separated after almost two decades together. What happened to the famous Hollywood...
Why Does Netflix Remove Shows? List of Shows Being Removed in 2026
Curious, why does Netflix remove shows from its library? There are several points that Netflix keeps in mind while removing...
Social Security Recipients Could See Larger Payment Adjustment in 2027 Amid Higher Inflation
By Jack Phillips A senior citizens group has forecast that the cost-of-living adjustment (COLA) for Social Security payments will increase...
OPEC Oil Production Plunges 30 Percent Since Start of Iran War
By Andrew Moran Crude oil production has declined by more than 30 percent since the start of the war in...
Trump, Xi to Meet for 2nd Day of Talks, With Discussion Expected on Taiwan, Iran, Purchases
By Andrew Moran President Donald Trump will meet Chinese leader Xi Jinping for the second day of their summit on...